Categories Consumer

Nexstar agrees to buy Tribune for $4.1 billion

Nexstar Media Group Inc. (NXST) agreed to acquire Tribune Media Group Inc. (TRCO) for $4.1 billion. The all-cash deal values Tribune at $46.50 a share, and including debt, amounts to $6.4 billion. The transaction is expected to close in the third quarter of 2019 and bring significant synergies for Nexstar.

If the deal goes through, it would create the biggest television broadcasting company in the US that would own over 200 TV stations. Tribune owns 39 TV stations and operates another three through marketing agreements. The deal will help Nexstar expand into larger markets and reach over 40% of US homes.

This deal comes after a failed attempt by Sinclair Broadcast Group Inc. (SBGI) to acquire Tribune four months ago. The deal faced criticism from regulators and following its termination, both companies filed lawsuits against each other which is still ongoing.

Tribune-Sinclair merger falls flat amid regulatory intervention

Several large companies in the media and entertainment industry are opting for mergers and acquisitions in order to deal with the increased competition from streaming services like Netflix (NFLX). This deal is expected to benefit Nexstar in terms of scale and growth and to bring significant returns to shareholders.

Nexstar’s shares are up over 8% so far this year while Tribune’s shares are up 4%. As of 12:25 pm ET, Nexstar’s stock was up 2.4% while Tribune’s shares soared 9.8%.

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top